Skip to main content

We’re not only bridging the barrier between mind and body, but we’re also making headlines with our innovative digital therapeutics.

PRESS RELEASES AND ANNOUNCEMENTS

Gut-Brain Connect: How metaMe’s Digital Therapeutic Hopes To Rewire IBS Treatment 

metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia discuss with Scrip plans for the… Read more

metaMe Health partners with Indegene to launch Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with Irritable Bowel Syndrome

Princeton, NJ, and Chicago, IL, United States, March 22, 2022 – Indegene, a technology-led global healthcare solutions provider, and metaMe Health… Read more

metaMe Health Raises $2.2 Million to Bring Its IBS Solution to Market

The launch of Regulora will provide accessible pain relief to the 10-15% of U.S. adults who live with IBS CHICAGO… Read more


COMPANY AND INDUSTRY NEWS

In just a few short years, digital therapeutics (DTx) have become an exciting, incredibly competitive new frontier in healthcare. For those not familiar… Read more

Digital therapeutics (DTx)—software that delivers a clinical mechanism of action, either alone or in combination with other standard-of-care treatments… Read more

Chicago Bootcamps featured metaMe Health in their list of the 60 Chicago Startups to Watch in 2020. The list highlights the most promising companies… Read more

STAY CONNECTED TO THE FUTURE OF
PRESCRIPTION DIGITAL THERAPIES

Join our mailing list. Or to become an investor, contact us directly.